Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Product/R&D News
9/13/2025
Denovo's Publishes Landmark Trial in Precision Psychiatry in JAMA
9/12/2025
China Approves FirboX's Fibroblast-Based Therapy for Clinical Trials
9/11/2025
Novartis Gains Expanded Approval for Tabrecta in China
9/11/2025
Henlius' HLX43 Shows Promising Results in Phase I Trial
9/11/2025
IDEAYA's IDE849 Shows Strong Results in Phase I Trial
9/9/2025
RemeGen's Telitacicept Advances in Sjögren's Syndrome
9/9/2025
BioNTech and BMS Report Promising Global Phase II Data for Pumitamig
9/8/2025
Junshi Achieves Positive Phase 3 Results for JS005 in Psoriasis Treatm...
9/8/2025
Innovent's Tigulixostat Demonstrates Superior Efficacy in Phase 2 Gout...
9/8/2025
Atom Thera Achieves Positive Phase 2b/3 Trial Results for Lingdolinura...
9/8/2025
Baili and BMS Present Promising Data on EGFR/HER3 Bispecific ADC for F...
9/8/2025
Avadel Partners with XWPharma to Advance Valiloxybate for Sleep Disord...
9/5/2025
Yangtze River's Fexuprazan Gains Chinese Approval
9/5/2025
3SBio Secures IND Nod for Dual-Target CAR-T Therapy SA102
9/5/2025
BioNTech and DualityBio Score Phase III Win with Promising ADC in Brea...
9/4/2025
Baili-Bio Launches Phase 3 Trial for HER2-Targeted ADC in Gastric Canc...
9/3/2025
Ab&B Bio-Tech Gains Approval for First Quadrivalent Subunit Influenza ...
9/2/2025
Nine First-in-Class Drugs Receive Initial Clinical Approval in China
9/2/2025
China Approved Seven New Drugs in August
9/1/2025
BioNTech Launches Phase 1/2 Trial of BNT327 and BNT3212 in Advanced Tu...
9/1/2025
Hongcheng Launches Phase II Trial for PD-1/CTLA-4/VEGF TsAb in Advance...
9/1/2025
Novel iPSC-Derived Neural Cell Therapy Shows Promise in SCI Treatment
9/1/2025
Hengrui Seeks NMPA Approval for New Dual-Receptor Obesity Drug HRS9531
8/30/2025
CMS Subsidiary Gets Approval to Launch Clinical Trials of Povorctinib
8/29/2025
D3 Bio's D3S-001 Receives FDA Breakthru Therapy and Orphan Drug Design...
8/29/2025
Boehringer's Zongertinib Gains Conditional Approval in China
8/29/2025
Hengrui's SHR2554 Receives Conditional NMPA Approval
8/29/2025
Akeso Advances First Bispecific ADC Into Clinical Stage With First Pat...
8/26/2025
Akeso's Ivonescimab Secures First Demonstrated OS Benefit in Lung Can...
8/26/2025
Arnatar Debuts with FDA Designations for Alagille Syndrome Candidate A...
Page:
1
/
19
Total number of articles:
568
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit